Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin 81mg vs 162mg for Preeclampsia Prevention in Obese Women
NCT03735433Phase 4Terminated
- Sponsor
- The Ohio State University
- Start
- Jan 2019
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin in preeclampsia, sponsored by The Ohio State University. Primary endpoint: Incidence of Diagnosis of Preeclampsia at 10 months. Started Jan 2019; status: terminated.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT03735433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03735433.